在肺腺癌中鉴定一种新型 ALK 抑制剂敏感的 PRKCE - ALK 基因融合物。
Mesh : Humans Anaplastic Lymphoma Kinase / genetics antagonists & inhibitors Lung Neoplasms / genetics drug therapy pathology Protein Kinase Inhibitors / therapeutic use pharmacology Adenocarcinoma of Lung / genetics drug therapy pathology Oncogene Proteins, Fusion / genetics Adenocarcinoma / genetics drug therapy pathology Receptor Protein-Tyrosine Kinases / genetics Female Male Crizotinib / therapeutic use pharmacology Middle Aged
来 源: DOI:10.1016/j.lungcan.2024.107797